BlackRock Health Sciences Trust II:BMEZ

    Manage Alerts


    As of 6/29/2022

    52 Wk Avg$24.11$25.83-7.15%
    52 Wk High$29.99$30.740.44%
    52 Wk Low$14.96$17.79-17.91%
    Regular Distribution TypeIncome Only
    Distribution Rate10.67%
    Distribution Amount$0.1450
    Distribution FrequencyMonthly
    Past performance is no guarantee of future results.

    Basic Information

    Investment Objective

    BlackRock Health Sciences Trust II (the “Trust”) is a newly-organized, non-diversified, closed-end management investment company with no operating history. The Trust’s investment objectives are to provide total return and income through a combination of current income, current gains and long-term capital appreciation. There can be no assurance that the Trust’s investment objectives will be achieved or that the Trust’s investment program will be successful.

    Capital Structure

    As of 6/29/2022

    Total Investment Exposure:$2,151.478M
    Total Common Assets:$2,134.063M
    Common Shares Outstanding:112,669,825

    As of 6/29/2022

    Preferred Share Assets:
    Total Debt (USD): $6.245M
    Regulatory Leverage (USD): $6.245M
    Effective Leverage (USD): $6.245M
    Effective Leverage (%): 0.29%
    Annual Expense Ratios

    As of 12/31/2021

      Per Common Share
    Management FeesN/A
    Other Expenses:N/A
    Baseline Expense: N/A
    Interest Expense:N/A
    Total: 1.30%
    Fund Management

    Fund Sponsor

    Portfolio Managers
    Xiang Liu, Christopher M. Accettella, Jeffrey Lee, Erin Xie, Kyle McClements

    Category: Equity-Sector Equity
    Ticker: BMEZ
    NAV Ticker: XBMZX
    Average Daily Volume (shares): 269,577
    Average Daily Volume (USD): $5.656M
    Inception Date: 1/29/2020
    Inception Share Price: $20.00
    Inception NAV: $20.00
    Tender Offer: No
    Term: No
    Fiscal Year End: December 31
    Third Party Links & Reports


    As of 6/29/2022

    Past performance is no guarantee of future results.
    Distribution History

    Enter declared start and end dates to display distribution history below. Income, Long Gain, Short Gain and ROC breakdowns will only be shown for the past year.

    Declared Date Payable Date Ex Date Distrib Amount Income Long Gain Short Gain ROC

    *Indicates a Special Distribution: A distribution disbursed in addition to the normal distributions paid out by the company.

    Key Information Regarding Distributions
    Avg. Earnings Per Share:
    As of 12/31/2021
    Annualized Distribution Rate on NAV:
    As of 6/29/2022
    Total Return on NAV (12 months):
    As of 6/29/2022
    Avg. Portfolio Coupon:
    As of 6/29/2022
    Total % Portfolio Effectively Leveraged:
    As of 6/29/2022

    Pricing Information

    Premium/Discount Information
    Past performance is no guarantee of future results.
    Premium/Discount Information

    As of 6/30/2022

    PeriodAvg Discount
    6 Month-9.87%
    1 Year-7.15%
    3 Year 
    5 Year 

    As of 6/29/2022

    3 Month-0.22
    6 Month-0.83
    1 Year-1.43
    Pricing History
    Date NAV Premium / Discount


    Calendar Year Total Returns

    As of 5/31/2022
    Category: Morningstar US CEF Sector Equity

    Past 20 Years

    Return YearPriceNAVCategory - PriceCategory - NAV
    Past performance is no guarantee of future results.
    Annualized Total Returns

    Returns for periods less than one year are cumulative rather than annualized

    As of 5/31/2022
    Category: Morningstar US CEF Sector Equity

    Past performance is no guarantee of future results.

    Portfolio Characteristics

    Portfolio Characteristics
    Average Coupon:
    As of 6/29/2022
    Number of Holdings:
    As of 3/31/2022
    Annual Portfolio Turnover:
    As of 12/31/2021
    Asset Allocation

    As of 3/31/2022

    Top Sectors

    As of 3/31/2022

    Defensive (Super Sector)87.54%
    Cash Equivalents3.41%
    Cash Equivalents (Super Sector)3.41%
    Cyclical (Super Sector)2.89%
    Financial Services2.00%
    Basic Materials0.89%
    Future Forward0.00%
    Derivative (Super Sector)0.00%
    Top Holdings

    As of 3/31/2022

    HoldingValue% Portfolio
    Seagen Inc Ordinary Shares$69.26M2.74%
    Vertex Pharmaceuticals Inc$61.50M2.43%
    Alcon Inc$58.40M2.31%
    ResMed Inc$47.72M1.89%
    Intuitive Surgical Inc$44.66M1.77%
    DexCom Inc$44.33M1.75%
    UCB SA$41.55M1.64%
    Horizon Therapeutics PLC$40.75M1.61%
    LHC Group Inc$39.33M1.55%
    Hologic Inc$37.66M1.49%
    Maturity Breakdown

    As of 3/31/2022

    Country Allocation

    As of 3/31/2022

    Country% Portfolio
    United States - Equity74.79%
    Switzerland - Equity4.66%
    Belgium - Equity2.31%
    Denmark - Equity2.16%
    Germany - Equity1.54%
    China - Equity1.48%
    United Kingdom - Equity1.46%
    Japan - Equity1.28%
    Italy - Equity0.52%
    Ireland - Equity0.50%

    Closed-end fund historical distribution sources have included net investment income, realized gains, and return of capital. For more detailed information on the distributions of a specific fund, please visit the sponsor's website.


    Distribution type sourced from Morningstar. For specific information about a fund's distribution sources, visit the fund sponsor's website.

    The following information applies to closed-end funds in general: Fund shares are not guaranteed or endorsed by any bank or other insured depository institution, and are not federally insured by the Federal Deposit Insurance Corporation. Shares of closed-end funds are subject to investment risks, including the possible loss of principal invested. There can be no assurance that fund objectives will be achieved. Closed-end funds frequently trade at a discount to their net asset value. NAV returns are net of fund expenses, and assume reinvestment of distributions.